Market Overview:
The global menopause treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of menopause, rising awareness about available treatments, and technological advancements in the field of menopause treatment. The hormonal treatment segment is expected to dominate the global menopause treatment market during the forecast period. This can be attributed to factors such as their efficacy and long-term safety profile. The non-hormonal treatment segment is projected to grow at a higher CAGR during the forecast period owing to its growing popularity among women who are unwilling or unable to take hormone therapy for various reasons such as health concerns or side effects associated with it. In terms of application, hospitals are expected dominate the global Menopause Treatment Market during 2018-2030 followed by clinics due high patient footfall and better reimbursement scenario in developed countries across North America.
Product Definition:
Menopause is a natural stage in a woman's life. It is the time when her menstrual periods stop and she can no longer get pregnant. Treatment may include hormone therapy, which can help relieve some of the symptoms of menopause.
Hormonal Treatment:
Hormonal treatment is used by women to regulate the hormonal imbalance in their bodies. The most common symptoms of hormonal imbalance are hot flashes, night sweats, mood swings and other such symptoms. Hormonal treatment helps to restore the natural balance of hormones in a woman's body and eliminates or reduces the adverse effects of these changes.
Non-Hormonal Treatment:
Non-hormonal treatment is used for the reduction of symptoms associated with menopause such as hot flashes, mood swings, and insomnia. The treatment includes various therapies including herbal medicines and vitamins. Herbal supplements include bio identical drugs that are FDA approved to reduce hot flashes; whereas vitamin therapy includes products like Vitamin E & K2 which help in reducing risks associated with heart disease & osteoporosis along with improving night sweats.
Application Insights:
Menopause treatment finds application in various fields including hospitals, clinics, and others. Hospitals held the largest share of the menopause treatment market in 2017 owing to availability of advanced healthcare facilities along with a high number of women patients suffering from menopausal symptoms.
The others segment includes companies offering home delivery services for menopause medicines as well as non-prescription drugs for treating menopausal symptoms at home. Increasing awareness about health issues among older population is expected to drive this segment over the forecast period.
Menopause has been found to be one of the most common reasons leading to visits to doctors or hospitals by women aged 45 years.
Regional Analysis:
In 2017, North America dominated the global menopause treatment market with a revenue share of over 40%. The rising prevalence of climacteric disorders and increasing awareness about menopausal health are some factors responsible for its large share. In addition, the presence of well-established healthcare facilities and favorable reimbursement policies are anticipated to drive regional growth. Moreover, an increase in R&D investments by major players is contributing to its growth. For instance, in May 2018, Pfizer Inc., one of the major U.S.-based pharmaceutical companies invested around USD X million for research on innovative therapies for women's health conditions including osteoporosis and hot flashes associated with menopause transition (HRH).
Growth Factors:
- Increasing awareness about the symptoms and treatment options for menopause among women.
- Growing number of women who are entering into their perimenopausal and postmenopausal years.
- Rising incidence of health conditions such as obesity, cardiovascular diseases, and osteoporosis that are associated with menopause.
- increasing demand for minimally invasive procedures for treating menopause-related symptoms 5 Increased focus on preventive healthcare among women
Scope Of The Report
Report Attributes
Report Details
Report Title
Menopause Treatment Market Research Report
By Type
Hormonal Treatment, Non-Hormonal Treatment
By Application
Hospitals, Clinic, Others
By Companies
Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Menopause Treatment Market Report Segments:
The global Menopause Treatment market is segmented on the basis of:
Types
Hormonal Treatment, Non-Hormonal Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Allergan
- Emcure Pharmaceuticals
- Eli Lilly And Company
- Cipla
- Teva Pharmaceutical Industries
Highlights of The Menopause Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormonal Treatment
- Non-Hormonal Treatment
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Menopause Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one answer to this question as the best menopause treatment will vary depending on a woman's individual circumstances. However, some common treatments for menopause include hormone therapy, lifestyle changes such as exercise and weight loss, and surgery.
Some of the major players in the menopause treatment market are Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla, Teva Pharmaceutical Industries.
The menopause treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Menopause Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Menopause Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Menopause Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Menopause Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Menopause Treatment Market Size & Forecast, 2018-2028
4.5.1 Menopause Treatment Market Size and Y-o-Y Growth
4.5.2 Menopause Treatment Market Absolute $ Opportunity
Chapter 5 Global Menopause Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Menopause Treatment Market Size Forecast by Type
5.2.1 Hormonal Treatment
5.2.2 Non-Hormonal Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Menopause Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Menopause Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Menopause Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Menopause Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Menopause Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Menopause Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Menopause Treatment Market Size Forecast by Type
9.6.1 Hormonal Treatment
9.6.2 Non-Hormonal Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Menopause Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Menopause Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Menopause Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Menopause Treatment Market Size Forecast by Type
10.6.1 Hormonal Treatment
10.6.2 Non-Hormonal Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Menopause Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Menopause Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Menopause Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Menopause Treatment Market Size Forecast by Type
11.6.1 Hormonal Treatment
11.6.2 Non-Hormonal Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Menopause Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Menopause Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Menopause Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Menopause Treatment Market Size Forecast by Type
12.6.1 Hormonal Treatment
12.6.2 Non-Hormonal Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Menopause Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Menopause Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Menopause Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Menopause Treatment Market Size Forecast by Type
13.6.1 Hormonal Treatment
13.6.2 Non-Hormonal Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Menopause Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Menopause Treatment Market: Competitive Dashboard
14.2 Global Menopause Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Novartis
14.3.3 Novo Nordisk
14.3.4 Pfizer
14.3.5 Allergan
14.3.6 Emcure Pharmaceuticals
14.3.7 Eli Lilly And Company
14.3.8 Cipla
14.3.9 Teva Pharmaceutical Industries
